Prepare a perimenopause visit without diagnosing yourself
Qualitative reviews keep finding the same clinic gap: people arrive with a messy month, and the visit collapses into periods or a single blood test. Hoga and colleagues (2015), synthesizing 24 qualitative studies, reported that clinicians often under-attend to what the change means in daily life.
You do not fix that by diagnosing yourself in the waiting room. You fix it by arriving with three things a clinician can use.
First, a pattern: what you notice, how often, how severe, and how much it interferes with sleep, work, or mood. A descriptive log is enough. Frequency and interference matter more than a clever label.
Second, context a questionnaire might miss: prior depression, heavy bleeding, night sweats, care load, medicines. The 2018 perimenopausal depression guidelines already ask clinicians to screen. They do not ask an app to score you.
Third, a short ask: what you want from this visit — investigation, treatment options, or a plan for the next six months. NAMS statements exist so a clinician can apply them to a whole history, including contraindications this app does not collect.
ClearDay’s clinician summary is a plain-text pack of those three lists. It is not a referral, a diagnosis, or a request for a specific prescription.
What this article cannot tell you
- What your clinician will diagnose.
- Which treatment they will offer.
- Whether you “need” hormone therapy.
Questions worth taking to a clinician
- Here is what has been most bothersome for four weeks. What would you investigate first?
- What should I bring to the next visit that would change the plan?
Sources
- Hoga L, Rodolpho J, Gonçalves B, Quirino B. Women's experience of menopause: a systematic review of qualitative evidence. JBI Database of Systematic Reviews and Implementation Reports. 2015. doi:10.11124/jbisrir-2015-1948
- Maki PM, Kornstein SG, Joffe H, Bromberger JT, Freeman EW, Athappilly G, Bobo WV, Rubin LH, Koleva HK, Cohen LS, Soares CN. Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations. Journal of Women's Health. 2018. doi:10.1089/jwh.2018.27099.mensocrec
- The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022. doi:10.1097/GME.0000000000002028